Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE dips after Trump win though pharma, gold miners surge

Wed, 09th Nov 2016 09:58

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 down 0.1 pct

* Gold miners, pharma stocks rally

* U.S.-exposed firms also gain

By Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index fell onWednesday after a shock win for Republican Donald Trump in theU.S. presidential election sent markets lower, though goldminers and pharma stocks soared.

Trump defeated favourite Hillary Clinton in Tuesday'selection, putting the U.S. on an uncertain path and promptinginvestors to dump risky assets such as stocks.

The blue chip FTSE 100 index fell 0.1 percent to6,837.87 points by 0932 GMT, having rallied in the previoussession on expectation of a Clinton victory. The moredomestically-focused FTSE 250 index rose 0.2 pct.

The FTSE 100 had opened 2 percent lower, but recovered offits lows. Analysts cited Trump's acceptance speech as soothinginvestor nerves.

"I think the market over-reacted slightly this morning,"John Moore, advisory investment manager at Berkeley Capital,said, adding that he wouldn't be surprised if the FTSE 100turned positive.

"I think Trump is pro-business. The thing is, lookingtowards the FTSE, there are several stocks that will benefitfrom a Trump victory, such as the pharmaceuticals sector.Hillary Clinton wanted to impose tighter regulations, whereasTrump is opposed to that."

Healthcare stocks Hikma, Shire, Astrazeneca and GlaxoSmithKline rallied, gaining between 2percent to 6.7 percent on the back of Trump's win.

Pharma stocks had been losing ground in the run-up to theelection on worries that a Clinton presidency would put pressureon drug prices.

Some companies with significant exposure to the United Statesalso rose. CRH a construction firm which had been toutedas a potential beneficiary from any increase in U.S.infrastructure spending, jumped 7 percent, as it derives 50percent of its revenues from there. U.S.-focused Ashtead also soared 7.6 percent.

Investors' flight to safety buoyed shares in precious metalsminer Fresnillo, which jumped over 9 percent, alongwith Randgold Resources, which gained more than 7percent after the price of gold surged.

Shares in banking stocks, however, came underpressure, while British grocers fell after Sainsbury reported an underwhelming set of results and dropped 3.2percent. The supermarket reported a third straight decline infirst-half profit, hurt by a fall in sales. (Reporting by Kit Rees; Editing by Toby Chopra)

More News
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.